Forest Laboratories Announces Successful Completion of Tender Offer for Securities of Clinical Data

Forest Laboratories, Inc. FRX today announced that its indirect wholly-owned subsidiary, Magnolia Acquisition Corp., has accepted for purchase all of the securities validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of, and certain outstanding notes and warrants convertible into or exercisable for the common stock of, Clinical Data, Inc. CLDA. Upon completion of the merger, Clinical Data will become a wholly-owned subsidiary of Forest and Clinical Data's common stock will cease to be traded on the NASDAQ.